±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 469  |  »Ø¸´: 0

allpeptide

Òø³æ (ÕýʽдÊÖ)

[½»Á÷] ¿¹¾úëÄLL(17-29)£¬LL-37 FK-13|717919-68-1|FKRIVQRIKDFLR

ÈËÔ´ÐÔ¿¹¾úëÄLL-37¾ßÓкÜÇ¿µÄ¿¹¾úºÍ¿¹Ñ×»îÐÔ£¬¹ãÆ×¿¹¾úЧ¹ûºÅ£¬µ«ÓÉÓÚÆä·Ö×ÓÁ¿±È½Ï´ó£¬²¢ÇÒÔÚÉúÎïÌåÄÚµÄϸ°ûÑ¡ÔñÐԵͣ¬¼ÓÖ®Éú²ú³É±¾¸ß£¬Òò´ËÏÞÖÆÁËLL-37ÔÚÖÎÁÆ·½ÃæµÄÓ¦Óá£Òò´Ë¿ª·¢³öеÄLL-37ÑÜÉúµÄ¶Ì¦Á-ÂÝÐý¿¹¾úëÄ£¬ÕâÀàÐòÁн϶̵Ŀ¹¾úëľßÓиüºÃµÄϸ°ûÑ¡ÔñÐÔ£¬²¢ÇÒÓëLL-37Ïà±È£¬Æä¿¹Ñ×»îÐÔûÓÐÃ÷ÏÔµÄËðʧ¡£LL-37 FK-13¾ÍÊÇLL-37ÑÜÉúµÄ¶Ì¦Á-ÂÝÐý¿¹¾úëÄÖеÄÒ»ÖÖ£¬ÓÉ13¸ö°±»ùËá×é³É£¬¾ßÓкܸߵÄϸ°ûÑ¡ÔñÐԺͿ¹Ñ×»îÐÔ¡£Ñо¿±íÃ÷LL-37 FK-13¿ÉÒÔͨ¹ýÉøÍ¸Ï¸°ûĤºÍÆÆ»µÄ¤µÄÍêÕûÐÔÀ´É±ËÀ΢ÉúÎïϸ°û¡£

LL-37µÄºËÐÄÐòÁÐFK-13±»¼¡¶¯µ°°×±£»¤ÃâÊÜϸ¾úµ°°×Ë®½â¡£FK-13±íÏÖ³ö¿¹HIV-1¡¢ECµÄ»îÐÔ₅₀ 3.4΢Ãס£ÓÉÓÚN-Ä©¶Ë±½±û°±ËáµÄÈ¥³ýµ¼ÖÂʧ»î£¬FKRIVQRIKDFLR¶ÔÓ¦ÓÚÈËÀàLL-37µÄ×îС¿¹HIVÇøÓò¡£

FK-13, core sequence of LL-37, is protected from bacterial proteolysis by actin. FK-13 showed activity against HIV-1, EC₅₀ 3.4 ¦ÌM. As removal of the N-terminal phenylalanine leads to inactivation, FKRIVQRIKDFLR corresponds to the minimal anti-HIV region of human LL-37.

img

񅧏: 189236

ÖÐÎÄÃû³Æ: LL(17-29)£¬LL-37 FK-13

Ó¢ÎÄÃû: LL-37 FK-13 trifluoroacetate salt

Ó¢ÎÄͬÒå´Ê: Cationic Antimicrobial Protein 18 (150-162) (human), LL-37 (17-29), hCAP18 (150-162) AND LL17 - 29

CASºÅ: 717919-68-1

µ¥×Öĸ: H2N-FKRIVQRIKDFLR-OH

Èý×Öĸ: H2N-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-COOH

°±»ùËá¸öÊý: 13

·Ö×Óʽ: C80H135N25O17

ƽ¾ù·Ö×ÓÁ¿: 1719.09

¾«È··Ö×ÓÁ¿: 1718.05

µÈµçµã(PI): 12.25

pH=7.0ʱµÄ¾»µçºÉÊý: 3.98

ƽ¾ùÇ×Ë®ÐÔ: 0.48461538461538

ÊèË®ÐÔÖµ: -0.44

À´Ô´: È˹¤»¯Ñ§ºÏ³É£¬½öÏÞ¿ÆÑ§Ñо¿Ê¹Ó㬲»µÃÓÃÓÚÈËÌå¡£

´¿¶È: 95%¡¢98%

ÑÎÌåϵ: ¿ÉÑ¡TFA¡¢HAc¡¢HCl»òÆäËü

Éú³ÉÖÜÆÚ: 2-3ÖÜ

´¢´æÌõ¼þ: ¸º80¡æÖÁ¸º20¡æ

±êÇ©: ¤ø¿¹¾úëÄ(Antimicrobial Peptides)  ¤ø²¡¶¾Ñ§
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

½öרעºÏ³É¶àëÄ£¬¶àëĵķ¢Õ¹·½Ïò¡¢½á¹¹¡¢×÷ÓᢺϳÉÓë´¿»¯£¬µ±Ç°¶àëĽçµÄÐÂÎÅ¡£Î¢ÐżûÃû×Ö
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ allpeptide µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬335·Ö£¬0856£¬Çóµ÷¼ÁԺУºÍµ¼Ê¦ +14 Çã____Ïô 2026-03-27 15/750 2026-04-02 09:21 by olim
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +7 Ë«ÂíβƦÀϰå2 2026-04-01 7/350 2026-04-02 06:08 by 286640313
[¿¼ÑÐ] ²ÄÁÏר˶322·Ö +10 ¹þ¹þ¹þºðºðºð¹þ 2026-04-01 10/500 2026-04-01 22:19 by Dyhoer
[¿¼ÑÐ] ʳƷѧ˶362Çóµ÷¼Á +3 xuanxianxian 2026-04-01 3/150 2026-04-01 21:05 by °¡Àî999
[¿¼ÑÐ] 085601²ÄÁϹ¤³ÌÕÒµ÷¼Á +20 oatmealR 2026-03-29 21/1050 2026-04-01 21:00 by lijunpoly
[¿¼ÑÐ] 085600£¬320·ÖÇóµ÷¼Á +5 ´ó²öС×Ó 2026-04-01 6/300 2026-04-01 19:40 by ÌÆãå¶ù
[¿¼ÑÐ] 0710ÉúÎïѧ¿¼Ñе÷¼Á +3 Àî¶àÃ×lee. 2026-03-27 4/200 2026-04-01 16:21 by zzchen2000
[¿¼ÑÐ] Ó¢Ò»Êý¶þÉúÎïÐÅϢѧ287·Ö£¬±¾¿ÆÉúÎï¿ÆÑ§£¬Çóµ÷¼Á +3 ±ÌË®xyz 2026-03-29 4/200 2026-04-01 15:35 by plum
[¿¼ÑÐ] Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +7 @taotao 2026-03-30 7/350 2026-04-01 14:30 by chenqifeng666
[¿¼ÑÐ] 085900ÍÁľˮÀû336·ÖÇóµ÷¼Á +3 Zhangjiangj 2026-03-31 5/250 2026-04-01 09:14 by Zhangjiangj
[¿¼ÑÐ] ¿¼ÑÐÉúÎïÓëÒ½Ò©µ÷¼Á +7 Ìúº©º©123425 2026-03-31 7/350 2026-04-01 08:45 by JourneyLucky
[¿¼ÑÐ] ½­ËÕËÕ±±¸ßУ³ÏÑûµ÷¼Áͬѧ +3 zzll406 2026-03-31 3/150 2026-03-31 16:54 by ¼°Ê±ÐÐÀÖfan
[¿¼ÑÐ] 11408×Ü·Ö309£¬Ò»Ö¾Ô¸¶«ÄÏ´óѧÇóµ÷¼Á£¬²»Ìôרҵ +5 Ì츳´øµ½THU 2026-03-29 6/300 2026-03-30 20:49 by dick_runner
[¿¼ÑÐ] һ־Ը˫һÁ÷»úе285·ÖÇóµ÷¼Á +4 ÐÒÔ˵ÄÈýľ 2026-03-29 5/250 2026-03-29 14:49 by Miko19
[¿¼ÑÐ] 340Çóµ÷¼Á +6 Amber00 2026-03-26 6/300 2026-03-29 12:06 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 305Çóµ÷¼Á +8 RuiFairyrui 2026-03-28 8/400 2026-03-29 08:22 by fmesaito
[¿¼ÑÐ] ҩѧ105500Çóµ÷¼Á +3 Ssun¡£¡£ 2026-03-28 3/150 2026-03-28 11:24 by lxf170613
[¿¼ÑÐ] 265Çóµ÷¼Á11408 +3 ÁõС¹lu 2026-03-27 3/150 2026-03-27 20:53 by nihaoar
[¿¼ÑÐ] 0856µ÷¼Á +5 ÇóÇóÈÃÎÒÓÐÊé¶Á° 2026-03-26 6/300 2026-03-27 15:12 by caszguilin
[¿¼ÑÐ] 292Çóµ÷¼Á +4 ÇóÇóÁËÊÕÏÂÎÒ°É£ 2026-03-26 4/200 2026-03-27 10:37 by zhshch
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û